Skip links
Companies
› United States › INTRA-CELLULAR THERAPIES, INC.
Company registry profile
INTRA-CELLULAR THERAPIES, INC. logo

INTRA-CELLULAR THERAPIES, INC.

Active

From the registry

Registration details

Registration No.
0451186689
Incorporation Date
2024-10-03
Company Type
Not disclosed
Address
Bedminster, United States
Website
www.intracellulartherapies.com/
Status
Active
Country
United States
Source: New Jersey Division of Revenue & Enterprise ServicesRegistry coverage
Registry summary

Company overview

INTRA-CELLULAR THERAPIES, INC. is a registered legal entity registered in United States under 0451186689, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 3 October 2024 and lists its registered address as Bedminster, United States. 5 shareholders are on record for INTRA-CELLULAR THERAPIES, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. Enterprise Services and was last updated on 17 October 2026.

Data Provenance
This record is sourced directly from official government registries, including New Jersey Division of Revenue & Enterprise Services.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Swipe or scroll for more columns

Shareholder Type Holding Source Document
FMR, LLC 17.5% New Jersey Division of Revenue & Enterprise Services
Vanguard Group Inc 15.3% New Jersey Division of Revenue & Enterprise Services
Blackrock Inc. 9.6% New Jersey Division of Revenue & Enterprise Services

Registry notes and limitations

Five shareholders are currently on record for INTRA-CELLULAR THERAPIES, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is FMR, LLC, holding 17.5% — the largest recorded stake — followed by Vanguard Group Inc at 15.3%; the remaining 3 shareholders shown hold smaller stakes.

The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Officers

5

SN
Sanjeev Narula ACTIVE

Residence
🇺🇸 United States
Occupation
Executive Vp, Cfo & Treasurer

RE
Robert E. Davis Ph.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vp & Chief Scientific Officer

KP
Karen Patruno Sheehy Esq. ACTIVE

Residence
🇺🇸 United States
Occupation
Senior Vp & Chief Compliance Officer

MN
Mark Neumann ACTIVE

Residence
🇺🇸 United States
Occupation
Evp & Chief Commercial Officer

JF
Juan Fernando Sanchez M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Vice President Of Corporate Communications & Investor Relations

Registry notes and limitations

The Executive Vp, Cfo & Treasurer of INTRA-CELLULAR THERAPIES, INC. currently on record is Sanjeev Narula; five officers are currently on record for INTRA-CELLULAR THERAPIES, INC., filed with New Jersey Division of Revenue & Enterprise Services.

The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at INTRA-CELLULAR THERAPIES, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Group Structure

Ultimate HQ
Johnson & Johnson
United States
Iti, Inc.
United StatesUS NY 3395110

How these relationships were recorded

INTRA-CELLULAR THERAPIES, INC. sits 1 level below its ultimate parent, Johnson & Johnson, registered in United States. 1 subsidiary is recorded beneath it, across 1 jurisdiction. The full chain up to Johnson & Johnson is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by INTRA-CELLULAR THERAPIES, INC.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Registry questions

Frequently asked questions

Who owns INTRA-CELLULAR THERAPIES, INC.?

Five shareholders are currently on record for INTRA-CELLULAR THERAPIES, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is FMR, LLC, holding 17.5% — the largest recorded stake — followed by Vanguard Group Inc at 15.3%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is INTRA-CELLULAR THERAPIES, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for INTRA-CELLULAR THERAPIES, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does INTRA-CELLULAR THERAPIES, INC. have on record?

5 shareholders are shown on record for INTRA-CELLULAR THERAPIES, INC.. The register reports 20 in total; only the top 5 by holding are shown here.

What is INTRA-CELLULAR THERAPIES, INC.'s company registration number?

INTRA-CELLULAR THERAPIES, INC.'s registration number is 0451186689, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.

Is INTRA-CELLULAR THERAPIES, INC. still an active company?

INTRA-CELLULAR THERAPIES, INC.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.

When was INTRA-CELLULAR THERAPIES, INC. incorporated?

INTRA-CELLULAR THERAPIES, INC. was incorporated on 3 October 2024, according to New Jersey Division of Revenue & Enterprise Services.

What is INTRA-CELLULAR THERAPIES, INC.'s registered address?

The registered address on file for INTRA-CELLULAR THERAPIES, INC. is Bedminster, United States.

Who are the officers/directors of INTRA-CELLULAR THERAPIES, INC.?

The Executive Vp, Cfo & Treasurer of INTRA-CELLULAR THERAPIES, INC. currently on record is Sanjeev Narula; five officers are currently on record for INTRA-CELLULAR THERAPIES, INC., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at INTRA-CELLULAR THERAPIES, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does INTRA-CELLULAR THERAPIES, INC. have a parent company or subsidiaries?

INTRA-CELLULAR THERAPIES, INC. sits 1 level below its ultimate parent, Johnson & Johnson, registered in United States. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

This website uses cookies to improve your web experience.